Not long ago, drug cost management typically entailed reductions in coverage for plan members in the form of lower coinsurance, increased deductibles, dispensing fee caps,…
Ira Gluskin: at least Madoff knew what people want. Low volatility.
The pitfalls and best practices of bringing investment in-house.
Much has been written over the last 36 months with respect to programs that have been implemented to help contain and manage drug plan costs.…
Demand for ETFs among institutions is being driven by liquidity.
Assessing the collateral damage from the great QE2 turnaround.
The past few years have been difficult for DB pension plans in Canada. Continued equity market volatility and, until recently, extremely low interest rates have…
There has been much discussion about Canada’s changing workplace demographics and a looming workforce shortage. Accordingly, Canada’s Aboriginal population—including First Nations, Inuit and Metis—are being…
Redemptions could drive selling in underlying bonds.
Many employers would like to reduce the risk in their DB plan so that the level of pension risk meets the company’s overall risk management…
Plan sponsors often offer them without understanding the issues and risks.
Why institutional trades might be harder for APs.
A lot of articles have been written lately about administrative services only (ASO) funding arrangements for health and dental benefits, specifically targeted at smaller-size organizations…